Cardiol Therapeutics (CRDL) Shares Issued (2020 - 2026)

Cardiol Therapeutics' Shares Issued history runs 7 years deep, the most recent figure standing at -$163.3 million for Q1 2026.

• Quarterly Shares Issued fell 224.91% year-over-year to -$163.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$163.3 million (down 224.91% YoY) and the FY2025 annual result came in at -$152.8 million, down 219.02% from the prior year.
• Shares Issued was -$163.3 million for Q1 2026 at Cardiol Therapeutics, down from -$152.8 million in the prior quarter.
• Across five years, Shares Issued topped out at $130.7 million in Q1 2025 and bottomed at -$163.3 million in Q1 2026.
• A 5-year average of $48.8 million and a median of $111.2 million in 2023 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2022 — Shares Issued jumped 110.97% — and 2026, when it sank 224.91%.
• Cardiol Therapeutics' Shares Issued stood at $108.7 million in 2022, then increased by 0.36% to $109.1 million in 2023, then climbed by 17.68% to $128.4 million in 2024, then plunged by 219.02% to -$152.8 million in 2025, then declined by 6.85% to -$163.3 million in 2026.
• Business Quant data shows CRDL's Shares Issued at -$163.3 million in Q1 2026, -$152.8 million in Q4 2025, and -$149.6 million in Q3 2025.